These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8109541)

  • 1. Economic outcomes and contemporary pharmacy practice.
    Reeder CE
    Am Pharm; 1993 Dec; NS33(12 Suppl):S3-6. PubMed ID: 8109541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research.
    Kozma CM; Reeder CE; Schulz RM
    Clin Ther; 1993; 15(6):1121-32; discussion 1120. PubMed ID: 8111809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three dimensions of managed care pharmacy practice.
    Gouveia WA; Shane R
    Am J Manag Care; 1997 Feb; 3(2):231-9. PubMed ID: 10169257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health outcomes analysis and its applications].
    Carrera-Hueso FJ
    Rev Med Univ Navarra; 1997; 41(4):237-44. PubMed ID: 10420964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating value-focused healthcare delivery systems: Part three--Core competencies.
    Beveridge RN
    J Oncol Manag; 1997; 6(6):16-23. PubMed ID: 10174597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
    Weintraub WS
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes research in pharmacy practice.
    Cooper JW
    Am Pharm; 1993 Dec; NS33(12 Suppl):S7-13. PubMed ID: 8109542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising strategies help employers integrate pharmacy and medical programs--and reap cost, quality advantages.
    Miller W
    Empl Benefits J; 2001 Sep; 26(3):23-7. PubMed ID: 11534217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy.
    Hepler CD
    Pharmacotherapy; 2004 Nov; 24(11):1491-8. PubMed ID: 15537552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for pharmacoeconomic studies of pharmacy services.
    Rascati KL; Moczygemba LR
    Clin Ther; 2007 Jul; 29(7):1488-90. PubMed ID: 17825700
    [No Abstract]   [Full Text] [Related]  

  • 14. Does cost-effectiveness play a role in clinical trials?
    Steele T; Pawaskar M; Balkrishnan R; Fleischer A; Feldman SR
    Dermatol Ther; 2007; 20(2):110-9. PubMed ID: 17537139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and justification of clinical pharmacy services.
    Anderson SV; Schumock GT
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):539-45. PubMed ID: 19941431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical care in community pharmacies: practice and research in Peru.
    Alvarez-Risco A; van Mil JW
    Ann Pharmacother; 2007 Dec; 41(12):2032-7. PubMed ID: 17940126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
    Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
    J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.